EDEM3 p.Pro746Ser
c.2236C>T · rs78444298 · VCV3068615
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8534 | likely pathogenic |
|---|---|---|
| REVEL | 0.245 | benign-leaning |
| SaProt | LLR -6.90 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | Δ0.26 | acceptor loss · deltas |
| Pangolin | Δ0.27 | loss · gain 0.21 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 0.86 | unconstrained · MANE · 16 kb · p 0.0044 · regional, not allelic |
| Overall | ||
| CADD | 25.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 2.09% | 48 |
| European (non-Finnish)grpmax | 1.88% | 53 |
| Finnishnot grpmax-eligible | 1.65% | 61 |
| Remaining individualsnot grpmax-eligible | 1.34% | 75 |
| South Asian | 0.661% | 151 |
| Admixed American | 0.541% | 185 |
| Amishnot grpmax-eligible | 0.329% | 304 |
| African / African-American | 0.257% | 389 |
| Middle Eastern | 0.215% | 466 |
| East Asian | 0.00448% | 22,329 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EDEM3
- Protein
- p.Pro746Ser
- Coding
- c.2236C>T
- MANE Select
- NM_025191
- dbSNP
- rs78444298
- Type
- single nucleotide variant
- Location
- chr1:184702964 (GRCh38)
- Gene constraint
- LOEUF 0.671 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 78.50
- Residue 746
- the pa domain; a UniProt-annotated variant site (in cdg2v; uncertain significance)
Disease context
congenital disorder of glycosylation, type 2v — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor EDEM3-CDG (Orphanet):
- Inheritance
- Autosomal recessive
Similar variants
- EDEM3 p.Asp554Val Uncertain significance ★★ ⚠ same condition
- EDEM3 p.Arg265Ter Likely pathogenic ★ same condition
- EDEM3 c.1692-28A>T Uncertain significance ★ same condition
- EDEM3 c.306-3T>A Uncertain significance ★ same condition
- EDEM3 p.Ala99Thr Uncertain significance ★ ⚠ same condition
- EDEM3 p.Val96Ile Uncertain significance ★ ⚠ same condition
- EDEM3 c.853+1G>T Pathogenic same condition
- EDEM3 p.Arg314Ter Pathogenic same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/edem3-p-pro746ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown